Cargando…

Angiogenic factor AGGF1 blocks neointimal formation after vascular injury via interaction with integrin α7 on vascular smooth muscle cells

Angiogenic factor AGGF1 (AngioGenic factor with G-patch and FHA (Forkhead-Associated) domain 1) blocks neointimal formation (formation of a new or thickened layer of arterial intima) after vascular injury by regulating phenotypic switching of vascular smooth muscle cells (VSMCs). However, the AGGF1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Yubing, Li, Yong, Peng, Huixin, Song, Qixue, Da, Xingwen, Li, Hui, He, Zuhan, Ren, Xiang, Xu, Chengqi, Yao, Yufeng, Wang, Qing K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968644/ https://www.ncbi.nlm.nih.gov/pubmed/35202649 http://dx.doi.org/10.1016/j.jbc.2022.101759

Ejemplares similares

Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury
por: Yao, Yufeng, et al.
Publicado: (2017)

Protein therapy of skeletal muscle atrophy and mechanism by angiogenic factor AGGF1
por: He, Zuhan, et al.
Publicado: (2023)

AGGF1 therapy inhibits thoracic aortic aneurysms by enhancing integrin α7-mediated inhibition of TGF-β1 maturation and ERK1/2 signaling
por: Da, Xingwen, et al.
Publicado: (2023)

Angiogenic Factor AGGF1 Activates Autophagy with an Essential Role in Therapeutic Angiogenesis for Heart Disease
por: Lu, Qiulun, et al.
Publicado: (2016)

Angiogenic Factor with G-patch and FHA Domain 1 (AGGF1) Expression in Human Vascular Lesions
por: Zhan, Maosheng, et al.
Publicado: (2016)

Contribution of Vascular Cells to Neointimal Formation
por: Yuan, Falei, et al.
Publicado: (2017)

Angiogenic Factor AGGF1 Promotes Therapeutic Angiogenesis in a Mouse Limb Ischemia Model
por: Lu, Qiulun, et al.
Publicado: (2012)

Mebendazole Reduces Vascular Smooth Muscle Cell Proliferation and Neointimal Formation Following Vascular Injury in Mice
por: Wang, Jintao, et al.
Publicado: (2014)

Curcumin inhibits proliferation, migration and neointimal formation of vascular smooth muscle via activating miR-22
por: Zhang, Minghua, et al.
Publicado: (2020)

Nrf2/Keap1 system regulates vascular smooth muscle cell apoptosis for vascular homeostasis: role in neointimal formation after vascular injury
por: Ashino, Takashi, et al.
Publicado: (2016)

MicroRNA-320 targeting neuropilin 1 inhibits proliferation and migration of vascular smooth muscle cells and neointimal formation
por: Li, Hongqiang, et al.
Publicado: (2019)

Role of PCK2 in the proliferation of vascular smooth muscle cells in neointimal hyperplasia
por: Ko, Dai Sik, et al.
Publicado: (2022)

High expression of angiogenic factor AGGF1 is an independent prognostic factor for hepatocellular carcinoma
por: Tu, Jianfei, et al.
Publicado: (2017)

Crucial Role of Hyaluronan in Neointimal Formation after Vascular Injury
por: Kashima, Yuichiro, et al.
Publicado: (2013)

Mig-6 Gene Knockout Induces Neointimal Hyperplasia in the Vascular Smooth Muscle Cell
por: Lee, Ju Hee, et al.
Publicado: (2014)

MiR-93 regulates vascular smooth muscle cell proliferation, and neointimal formation through targeting Mfn2
por: Feng, Shengdong, et al.
Publicado: (2019)

Smooth Muscle Endothelin B Receptors Regulate Blood Pressure but Not Vascular Function or Neointimal Remodeling
por: Miller, Eileen, et al.
Publicado: (2017)

Anemoside B4 Inhibits Vascular Smooth Muscle Cell Proliferation, Migration, and Neointimal Hyperplasia
por: Shan, Dan, et al.
Publicado: (2022)

Thymoquinone suppresses platelet‐derived growth factor‐BB–induced vascular smooth muscle cell proliferation, migration and neointimal formation
por: Zhu, Ning, et al.
Publicado: (2019)

Embryonic rat vascular smooth muscle cells revisited - a model for neonatal, neointimal SMC or differentiated vascular stem cells?
por: Kennedy, Eimear, et al.
Publicado: (2014)

S100B is required for maintaining an intermediate state with double-positive Sca-1+ progenitor and vascular smooth muscle cells during neointimal formation
por: Wu, Yan, et al.
Publicado: (2019)

Modulation of neointimal lesion formation by endogenous androgens is independent of vascular androgen receptor
por: Wu, Junxi, et al.
Publicado: (2014)

Different Responses of Neointimal Cells to Imatinib Mesylate and Rapamycin Compared with Normal Vascular Smooth Muscle Cells
por: Park, Yang Jin, et al.
Publicado: (2014)

Induction of ferroptosis promotes vascular smooth muscle cell phenotypic switching and aggravates neointimal hyperplasia in mice
por: Zhang, Shunchi, et al.
Publicado: (2022)

Use of rosiglitazone before and after vascular injury in hypercholesterolemic rabbits: Assessment of neointimal formation
por: Alessi, Alexandre, et al.
Publicado: (2008)

Cinnamic aldehyde inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia in Zucker Diabetic Fatty rats
por: Buglak, Nicholas E., et al.
Publicado: (2018)

Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation
por: Wu, Wen, et al.
Publicado: (2019)

Ant-Neointimal Formation Effects of SLC6A6 in Preventing Vascular Smooth Muscle Cell Proliferation and Migration via Wnt/β-Catenin Signaling
por: Rong, Zhihua, et al.
Publicado: (2023)

Age-Associated Dysregulation of Integrin Function in Vascular Smooth Muscle
por: Ojha, Krishna Raj, et al.
Publicado: (2022)

Extensive Proliferation of a Subset of Differentiated, yet Plastic, Medial Vascular Smooth Muscle Cells Contributes to Neointimal Formation in Mouse Injury and Atherosclerosis Models
por: Chappell, Joel, et al.
Publicado: (2016)

Chemerin Stimulates Vascular Smooth Muscle Cell Proliferation and Carotid Neointimal Hyperplasia by Activating Mitogen-Activated Protein Kinase Signaling
por: Xiong, Wei, et al.
Publicado: (2016)

Potent suppression of vascular smooth muscle cell migration and human neointimal hyperplasia by K(V)1.3 channel blockers
por: Cheong, Alex, et al.
Publicado: (2011)

The New Weapon to Inhibit Proliferation and Migration of Smooth Muscle Cell in Neointimal Formation
por: Chae, Cheong-Whan, et al.
Publicado: (2020)

Wood-Derived Vascular Patches Loaded With Rapamycin Inhibit Neointimal Hyperplasia
por: Xie, Boao, et al.
Publicado: (2022)

Integrin α9 regulates smooth muscle cell phenotype switching and vascular remodeling
por: Jain, Manish, et al.
Publicado: (2021)

Adropin inhibits the phenotypic modulation and proliferation of vascular smooth muscle cells during neointimal hyperplasia by activating the AMPK/ACC signaling pathway
por: Wang, Li, et al.
Publicado: (2021)

Smooth muscle cell‐specific Tgfbr1 deficiency attenuates neointimal hyperplasia but promotes an undesired vascular phenotype for injured arteries
por: Liao, Mingmei, et al.
Publicado: (2016)

Role of hsa_circ_0000280 in regulating vascular smooth muscle cell function and attenuating neointimal hyperplasia via ELAVL1
por: Wang, Zunzhe, et al.
Publicado: (2022)

PPARγ modulates vascular smooth muscle cell phenotype via a protein kinase G-dependent pathway and reduces neointimal hyperplasia after vascular injury
por: Yang, Han-Mo, et al.
Publicado: (2013)

Propylthiouracil-coated biodegradable polymer inhibited neointimal formation and enhanced re-endothelialization after vascular injury
por: Chang, Shang-Hung, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_n5p4vkt4359tqrf5625040ctng